Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk–benefit

Imagine a medicine that is expected to have very limited effects based upon knowledge of its pharmacology and (patho)physiology and that is studied in the wrong population, with low-quality studies that use a surrogate end-point that relates to the clinical end-point in a partial manner at most. Suc...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Heuberger, Jules A A C, Cohen Tervaert, Joost M, Schepers, Femke M L, Vliegenthart, Adriaan D B, Rotmans, Joris I, Daniels, Johannes M A, Burggraaf, Jacobus, Cohen, Adam F
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Science Inc 2013
Pynciau:
Reviews
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3690100/
https://ncbi.nlm.nih.gov/pubmed/23216370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12034
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg